Trombólisis en el anciano con infarto agudo de miocardio. El estudio PRIAMHO
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lee, 1995, For the GUSTO-1 Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an International trial of 41021 patients, Circulation, 91, 1659, 10.1161/01.CIR.91.6.1659
White, 1996, for the GUSTO-1 Investigators. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-1 Trial, Circulation, 94, 1826, 10.1161/01.CIR.94.8.1826
Weaver, 1991, The MITI Project Group: effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction, J Am Coll Cardiol, 18, 657, 10.1016/0735-1097(91)90784-7
Stason, 1987, Cardiovascular care of the elderly economic consideration, J Am Coll Cardiol, 18A, 10.1016/S0735-1097(87)80441-2
De los Reyes López, 1995, La Unidad Coronaria y el anciano con cardiopatia isquémica en España: De la información epidemiológica a la realidad clínica, Rev Esp Cardiol, 48, 44
1986, Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction, Lancet, 1, 397
1988, Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction, Lancet, 2, 349
1988, Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled trial, Lancet, 1, 545
1988, Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction, Lancet, 1, 349
1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results of all randomized trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4
Cabadés, 1996, en nombre de los investigadores del estudio «Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario » (PRIAMHO). Bases para un registro de infartos agudos de miocardio en España. El estudio PRIAMHO, Rev Esp Cardiol, 49, 393
Gurwitz, 1996, Recent age-related trends in the use of thrombolytic therapy of patients who have had acute myocardial infarction, Ann Intern Med, 124, 283, 10.7326/0003-4819-124-3-199602010-00001
Krumholz, 1997, Thrombolytic therapy for eligible elderly patients with acute myocardial infarction, JAMA, 277, 1683, 10.1001/jama.1997.03540450039032
Cabadés, 1999, Variabilidad en el manejo y pronóstico a corto y medio plazo del infarto de miocardio en España: el estudio PRIAMHO, Rev Esp Cardiol, 52, 767, 10.1016/S0300-8932(99)75004-9
Gurwitz, 1992, The exclusion of the elderly and women from clinical trials in acute myocardial infarction, JAMA, 268, 1417, 10.1001/jama.1992.03490110055029
Marrugat, 1997, Registros de morbimortalidad en cardiología: metodología, Rev Esp Cardiol, 50, 48, 10.1016/S0300-8932(97)73176-2
Sanz, 1999, El estudio PRIAMHO [comentario editorial], Rev Esp Cardiol, 52, 776, 10.1016/S0300-8932(99)75005-0
Maggioni, 1993, Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis. The Investigators of the Gruppo Italiano per lo studio della sovrevivenza nell'Infarto Miocardico (GISSI-2), N Engl J Med, 329, 1442, 10.1056/NEJM199311113292002
Pedro, 1991, Thrombolysis in acute myocardial infarction in the aged. A greater risk of cardiac rupture?, Rev Portug Cardiol, 10, 133
Honan, 1990, Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis, J Am Coll Cardiol, 16, 359, 10.1016/0735-1097(90)90586-E
Loukinan, 1989, Myocardial rupture complicating tissue plasminogen activator therapy of acute myocardial infarction, J Am Coll Cardiol, 13, 94
1989, Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction, N Engl J Med, 320, 618, 10.1056/NEJM198903093201002
1990, In-hospital mortality and clinical course of 20991 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with and without heparin, Lancet, 336, 71, 10.1016/0140-6736(90)91590-7
Chandra, 1997, Age-Related Trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study, Arch Intern Med, 157, 741, 10.1001/archinte.1997.00440280047004
De Jaegere, 1992, Intracraneal hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors, J Am Coll Cardiol, 19, 289, 10.1016/0735-1097(92)90480-B
Gore, 1991, Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study, Circulation, 83, 448, 10.1161/01.CIR.83.2.448
Mauri, 1989, Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated with streptokinase (the GISSI Trial), Am J Cardiol, 63, 1291, 10.1016/0002-9149(89)91037-0
Ross, 1990, The TTOPP Study: lessons from an aborted trial, J Myocardial Ischemia, 2, 65
Risch, 1990, Acute Myocardial Infarction in the Elderly, Cardiology, 77, 79
Grines, 1990, Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies, J Am Coll Cardiol, 16, 223, 10.1016/0735-1097(90)90482-5
Forman, 1992, Management of acute myocardial infarction in the very elderly, Am J Cardiol, 93, 315
Krunholz, 1994, Relationship of age with eligibility for thombolytic therapy and mortality among patients with suspected acute myocardial infarction, J Am Geriatr Soc, 42, 127, 10.1111/j.1532-5415.1994.tb04938.x
Behar, 1991, Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel, Am J Cardiol, 68, 1291, 10.1016/0002-9149(91)90233-B
Cragg, 1991, Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy, Ann Intern Med, 115, 173, 10.7326/0003-4819-115-3-173